BR0316205A - N-sulfonilaminotiazol - Google Patents
N-sulfonilaminotiazolInfo
- Publication number
- BR0316205A BR0316205A BR0316205-2A BR0316205A BR0316205A BR 0316205 A BR0316205 A BR 0316205A BR 0316205 A BR0316205 A BR 0316205A BR 0316205 A BR0316205 A BR 0316205A
- Authority
- BR
- Brazil
- Prior art keywords
- sulfonylaminothiazole
- sulphonylaminotiazol
- mides
- arylsulfone
- thiazolo
- Prior art date
Links
- BUPSWEAOWTYXRF-UHFFFAOYSA-N 3-(sulfonylamino)-2h-1,3-thiazole Chemical compound O=S(=O)=NN1CSC=C1 BUPSWEAOWTYXRF-UHFFFAOYSA-N 0.000 title 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 abstract 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 1
- 108010087999 Steryl-Sulfatase Proteins 0.000 abstract 1
- 102100038021 Steryl-sulfatase Human genes 0.000 abstract 1
- 125000005362 aryl sulfone group Chemical group 0.000 abstract 1
- DLGYNVMUCSTYDQ-UHFFFAOYSA-N azane;pyridine Chemical compound N.C1=CC=NC=C1 DLGYNVMUCSTYDQ-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Transplantation (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0226602A GB0226602D0 (en) | 2002-11-14 | 2002-11-14 | Organic compounds |
| GB0226616A GB0226616D0 (en) | 2002-11-14 | 2002-11-14 | Organic compounds |
| PCT/EP2003/012707 WO2004043968A1 (en) | 2002-11-14 | 2003-11-13 | N-sulfonylaminothiazole |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0316205A true BR0316205A (pt) | 2005-09-27 |
Family
ID=32313994
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0316205-2A BR0316205A (pt) | 2002-11-14 | 2003-11-13 | N-sulfonilaminotiazol |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7291734B2 (https=) |
| EP (1) | EP1562958B1 (https=) |
| JP (1) | JP4551767B2 (https=) |
| AR (1) | AR041952A1 (https=) |
| AT (1) | ATE396192T1 (https=) |
| AU (1) | AU2003288056A1 (https=) |
| BR (1) | BR0316205A (https=) |
| CA (1) | CA2505249A1 (https=) |
| DE (1) | DE60321209D1 (https=) |
| ES (1) | ES2305542T3 (https=) |
| MY (1) | MY135750A (https=) |
| PE (1) | PE20040693A1 (https=) |
| PT (1) | PT1562958E (https=) |
| TW (1) | TWI318212B (https=) |
| WO (1) | WO2004043968A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1976944A (zh) * | 2004-06-30 | 2007-06-06 | 默克公司 | 雌激素受体调节剂 |
| GB0505541D0 (en) * | 2005-03-17 | 2005-04-27 | Novartis Ag | Organic compounds |
| GB0505539D0 (en) * | 2005-03-17 | 2005-04-27 | Novartis Ag | Organic compounds |
| US20100204146A1 (en) | 2007-09-17 | 2010-08-12 | Preglem S.A. | Treatment of Oestrogen Dependant Conditions in Pre-menopausal Women |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1620508A1 (de) | 1965-07-23 | 1969-09-18 | Thomae Gmbh Dr K | Verfahren zur Herstellung neuer 4,5,6,7-Tetrahydrothiazolo-[5,4-c]-pyridine |
| DE2429195A1 (de) | 1974-06-18 | 1976-02-05 | Basf Ag | 2-amino-pyrazolo eckige klammer auf 3,4-d eckige klammer zu thiazole |
| GB8333514D0 (en) * | 1983-12-16 | 1984-01-25 | Erba Farmitalia | Tetrahydrothiazolo(5 4-c)pyridine derivatives |
| DE3533331A1 (de) * | 1985-09-18 | 1987-03-26 | Heumann Ludwig & Co Gmbh | Pyridothiazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| CO5261573A1 (es) * | 1999-11-19 | 2003-03-31 | Novartis Ag | Derivados de benzoxa y bezotiazol, compuesto y composicion farmaceutica que los contiene y proceso para la preparacion de la mencionada composicion |
| JP2001294572A (ja) * | 2000-02-09 | 2001-10-23 | Dai Ichi Seiyaku Co Ltd | 新規スルホニル誘導体 |
| SE0001899D0 (sv) * | 2000-05-22 | 2000-05-22 | Pharmacia & Upjohn Ab | New compounds |
| AU2002213467A8 (en) | 2000-10-11 | 2009-07-30 | Chemocentryx Inc | Modulation of ccr4 function |
| JP4266092B2 (ja) | 2001-10-09 | 2009-05-20 | 第一三共株式会社 | ジアミン誘導体 |
-
2003
- 2003-11-12 PE PE2003001143A patent/PE20040693A1/es not_active Application Discontinuation
- 2003-11-12 AR ARP030104165A patent/AR041952A1/es not_active Application Discontinuation
- 2003-11-13 WO PCT/EP2003/012707 patent/WO2004043968A1/en not_active Ceased
- 2003-11-13 EP EP03779918A patent/EP1562958B1/en not_active Expired - Lifetime
- 2003-11-13 AU AU2003288056A patent/AU2003288056A1/en not_active Abandoned
- 2003-11-13 AT AT03779918T patent/ATE396192T1/de not_active IP Right Cessation
- 2003-11-13 TW TW092131800A patent/TWI318212B/zh not_active IP Right Cessation
- 2003-11-13 US US10/533,335 patent/US7291734B2/en not_active Expired - Fee Related
- 2003-11-13 MY MYPI20034348A patent/MY135750A/en unknown
- 2003-11-13 PT PT03779918T patent/PT1562958E/pt unknown
- 2003-11-13 JP JP2004551017A patent/JP4551767B2/ja not_active Expired - Fee Related
- 2003-11-13 BR BR0316205-2A patent/BR0316205A/pt not_active IP Right Cessation
- 2003-11-13 CA CA002505249A patent/CA2505249A1/en not_active Abandoned
- 2003-11-13 DE DE60321209T patent/DE60321209D1/de not_active Expired - Lifetime
- 2003-11-13 ES ES03779918T patent/ES2305542T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US7291734B2 (en) | 2007-11-06 |
| TWI318212B (en) | 2009-12-11 |
| PT1562958E (pt) | 2008-08-26 |
| AU2003288056A1 (en) | 2004-06-03 |
| AR041952A1 (es) | 2005-06-01 |
| JP2006507321A (ja) | 2006-03-02 |
| JP4551767B2 (ja) | 2010-09-29 |
| EP1562958B1 (en) | 2008-05-21 |
| TW200504081A (en) | 2005-02-01 |
| PE20040693A1 (es) | 2004-11-23 |
| ES2305542T3 (es) | 2008-11-01 |
| DE60321209D1 (de) | 2008-07-03 |
| WO2004043968A1 (en) | 2004-05-27 |
| ATE396192T1 (de) | 2008-06-15 |
| MY135750A (en) | 2008-06-30 |
| CA2505249A1 (en) | 2004-05-27 |
| US20060247268A1 (en) | 2006-11-02 |
| HK1081541A1 (en) | 2006-05-19 |
| EP1562958A1 (en) | 2005-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69926806D1 (de) | N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren | |
| UY26082A1 (es) | Derivados de 1,4-diazabiciclo [3.2.2] nonan-4-carboxilato y -carboxamidas, su preparacion y su aplicacion en terapeutica | |
| DE69926919D1 (de) | N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren | |
| NO20012058L (no) | 2-ureido-tiazolderivater, fremgangsmåte for deres fremstilling og anvendelse som antitumormidler | |
| NL300356I1 (nl) | 6-mercapto-cyclodextrinederivaten: omkeermiddelen voor geneesmiddel-geindiceerde neuromusculaire blokkade | |
| ATE264852T1 (de) | Chinolinderivate als antibakterielle mittel | |
| FR15C0096I2 (fr) | Derives carbamoyloxyalkyl-azolium n-substitues | |
| NO20015667D0 (no) | Tiazoloderivater og farmasöytiske sammensetninger inneholdende dem | |
| DK1542997T3 (da) | Pyrazolylbenzothiazolderivater og deres anvendelse som terapeutiske midler | |
| NO20014128D0 (no) | Camptothecinderivater som har antitumoraktivitet | |
| ATE373665T1 (de) | Benzo-kondensierte heteroarylamid-derivative von thienopyridinen nützlich als therapeutische agentien, entsprechende pharmazeutische zusammensetzungen, und methoden für ihre verwendung | |
| BR0210205A (pt) | Antiinfecciosos | |
| PT1585548T (pt) | Composições e métodos de administração de agentes farmacológicos | |
| DE69906938D1 (de) | Glococorticoid selektive entzündungshemmende mittel | |
| ATE390426T1 (de) | Aminocyclische substituierte pyrrolopyrimidinderivate und pyrrolopyridinderivate | |
| PT1200412E (pt) | Agentes anti-proliferativos de imidazole | |
| DE69904804D1 (de) | Glucocorticoid selektive entzündungshemmende mittel | |
| BR0213464A (pt) | Derivados de 3-azabiciclo[3.1.0]hexano como antagonistas receptores de opióide | |
| DE60302221D1 (de) | Heteroaryl substituierte 2-pyridinyl und 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-onderivate | |
| PE20030061A1 (es) | 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4 | |
| ATE259362T1 (de) | Indolylpiperidinderivate als antihistaminische und antiallergische mittel | |
| ATE375359T1 (de) | Aminosterolderivate und ihre verwendungen | |
| EP1572169A4 (en) | DETECTION AND MODULATION OF SLIT AND ROBO-MEDIATED ANGIOGENESIS AND THEIR USE | |
| BR0316205A (pt) | N-sulfonilaminotiazol | |
| NO20040059L (no) | Benzo[G]kinolinderivater for behandling av glaukom og myopi |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012. |